Thermo Fisher Scientific (FRA:TN80) Cyclically Adjusted Book per Share: €2.27 (As of Mar. 2026)


FRA:TN80 Thermo Fisher Scientific Inc FRA:TN80
64 GF Score
Price €10.60
GF Value €12.31
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Thermo Fisher Scientific Cyclically Adjusted Book per Share?

Thermo Fisher Scientific FRA:TN80 64 Cyclically Adjusted Book per Share is €2.27 as of Mar. 2026. GuruFocus rates FRA:TN80 with a GF Score™ of 64/100 and a GF Value™ of €12.31 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Thermo Fisher Scientific's adjusted book value per share for the three months ended in Mar. 2026 was €3.292. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €2.27 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Thermo Fisher Scientific's average Cyclically Adjusted Book Growth Rate was 10.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 9.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 11.70% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Thermo Fisher Scientific was 13.30% per year. The lowest was 6.10% per year. And the median was 9.90% per year.

As of today (2026-07-11), Thermo Fisher Scientific's current stock price is €10.60. Thermo Fisher Scientific's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €2.27. Thermo Fisher Scientific's Cyclically Adjusted PB Ratio of today is 4.67.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Thermo Fisher Scientific was 9.75. The lowest was 3.11. And the median was 5.59.


Thermo Fisher Scientific  (FRA:TN80) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Thermo Fisher Scientific's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=10.60/2.27
=4.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Thermo Fisher Scientific was 9.75. The lowest was 3.11. And the median was 5.59.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Thermo Fisher Scientific Cyclically Adjusted Book per Share Related Terms


Thermo Fisher Scientific Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Thermo Fisher Scientific's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thermo Fisher Scientific Cyclically Adjusted Book per Share Chart

Thermo Fisher Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 2.27 2.25

Thermo Fisher Scientific Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.22 2.23 2.24 2.25 2.27

FRA:TN80 vs DHR, IDXX, A: Cyclically Adjusted Book per Share Comparison

For the Diagnostics & Research subindustry, Thermo Fisher Scientific's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thermo Fisher Scientific Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Thermo Fisher Scientific's Cyclically Adjusted PB Ratio falls into.


FRA:TN80
64GF Score
Thermo Fisher Scientific Inc FRA:TN80
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thermo Fisher Scientific Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Thermo Fisher Scientific's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=3.292/330.2130*330.2130
=3.292

Current CPI (Mar. 2026) = 330.2130.

Thermo Fisher Scientific Quarterly Data

Book Value per Share CPI Adj_Book
201606 1.307 241.018 1.791
201609 1.330 241.428 1.819
201612 1.413 241.432 1.933
201703 1.419 243.801 1.922
201706 1.391 244.955 1.875
201709 1.408 246.819 1.884
201712 1.457 246.524 1.952
201803 1.434 249.554 1.897
201806 1.531 251.989 2.006
201809 1.559 252.439 2.039
201812 1.642 251.233 2.158
201903 1.669 254.202 2.168
201906 1.729 256.143 2.229
201909 1.810 256.759 2.328
201912 1.824 256.974 2.344
202003 1.782 258.115 2.280
202006 1.826 257.797 2.339
202009 1.857 260.280 2.356
202012 1.947 260.474 2.468
202103 2.041 264.877 2.544
202106 2.118 271.696 2.574
202109 2.274 274.310 2.737
202112 2.493 278.802 2.953
202203 2.587 287.504 2.971
202206 2.781 296.311 3.099
202209 3.054 296.808 3.398
202212 2.895 296.797 3.221
202303 2.787 301.836 3.049
202306 2.850 305.109 3.084
202309 2.994 307.789 3.212
202312 3.019 306.746 3.250
202403 2.988 312.332 3.159
202406 3.142 314.175 3.302
202409 3.143 315.301 3.292
202412 3.387 315.605 3.544
202503 3.296 319.799 3.403
202506 3.158 322.561 3.233
202509 3.151 324.800 3.204
202512 3.302 324.054 3.365
202603 3.292 330.213 3.292

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €2.27 mean?
Thermo Fisher Scientific (FRA:TN80) has a Cyclically Adjusted Book per Share of €2.27 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Thermo Fisher Scientific and its competitors.
Is Thermo Fisher Scientific's Cyclically Adjusted Book per Share too high?
Thermo Fisher Scientific's current Cyclically Adjusted Book per Share is €2.27. Overall, Thermo Fisher Scientific has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Thermo Fisher Scientific's Cyclically Adjusted Book per Share compare to DHR and IDXX?
Thermo Fisher Scientific's Cyclically Adjusted Book per Share of €2.27 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Book per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Thermo Fisher Scientific and its competitors. Thermo Fisher Scientific's current Cyclically Adjusted Book per Share is €2.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thermo Fisher Scientific stock overvalued right now?
Based on GuruFocus' analysis, Thermo Fisher Scientific (FRA:TN80) is currently considered Modestly Undervalued. The stock's GF Value™ is €12.31, compared to a current price of €10.60 — trading 13.9% below its estimated fair value. The current Cyclically Adjusted Book per Share is €2.27. Thermo Fisher Scientific's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Thermo Fisher Scientific (FRA:TN80), the current Cyclically Adjusted Book per Share is €2.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Thermo Fisher Scientific (FRA:TN80) Overvalued in 2026?

Based on GuruFocus' analysis, Thermo Fisher Scientific stock appears to be undervalued. The current stock price of €10.60 is trading 13.9% below its estimated GF Value™ of €12.31. GuruFocus considers Thermo Fisher Scientific to be Modestly Undervalued.

Key valuation signals for FRA:TN80:

  • Cyclically Adjusted Book per Share: €2.27
  • GF Value™: €12.31 vs. price of €10.60 (13.9% below fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the FRA:TN80 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Thermo Fisher Scientific Business Description

Address 168 Third Avenue, Waltham, MA, USA, 02451
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
64GF Score

Get the complete analysis for FRA:TN80

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.60
Price
€12.31
GF Value